Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.16
STE's Cash to Debt is ranked lower than
88% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. STE: 0.16 )
Ranked among companies with meaningful Cash to Debt only.
STE' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.31 Max: 56.7
Current: 0.16
0.04
56.7
Equity to Asset 0.57
STE's Equity to Asset is ranked lower than
56% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. STE: 0.57 )
Ranked among companies with meaningful Equity to Asset only.
STE' s Equity to Asset Range Over the Past 10 Years
Min: 0.43  Med: 0.57 Max: 0.66
Current: 0.57
0.43
0.66
Interest Coverage 5.91
STE's Interest Coverage is ranked lower than
76% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.81 vs. STE: 5.91 )
Ranked among companies with meaningful Interest Coverage only.
STE' s Interest Coverage Range Over the Past 10 Years
Min: 7.1  Med: 16.05 Max: 22.23
Current: 5.91
7.1
22.23
F-Score: 4
Z-Score: 2.45
M-Score: -1.90
WACC vs ROIC
11.20%
5.10%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.51
STE's Operating margin (%) is ranked higher than
63% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.98 vs. STE: 9.51 )
Ranked among companies with meaningful Operating margin (%) only.
STE' s Operating margin (%) Range Over the Past 10 Years
Min: 7.06  Med: 12.52 Max: 16.2
Current: 9.51
7.06
16.2
Net-margin (%) 4.95
STE's Net-margin (%) is ranked higher than
56% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.15 vs. STE: 4.95 )
Ranked among companies with meaningful Net-margin (%) only.
STE' s Net-margin (%) Range Over the Past 10 Years
Min: 4.25  Med: 7.64 Max: 10.65
Current: 4.95
4.25
10.65
ROE (%) 5.97
STE's ROE (%) is ranked higher than
52% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.01 vs. STE: 5.97 )
Ranked among companies with meaningful ROE (%) only.
STE' s ROE (%) Range Over the Past 10 Years
Min: 6.65  Med: 12.93 Max: 18.11
Current: 5.97
6.65
18.11
ROA (%) 3.20
STE's ROA (%) is ranked higher than
56% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. STE: 3.20 )
Ranked among companies with meaningful ROA (%) only.
STE' s ROA (%) Range Over the Past 10 Years
Min: 3.85  Med: 6.98 Max: 10.46
Current: 3.2
3.85
10.46
ROC (Joel Greenblatt) (%) 20.80
STE's ROC (Joel Greenblatt) (%) is ranked higher than
64% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.53 vs. STE: 20.80 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
STE' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 16.35  Med: 29.93 Max: 38.9
Current: 20.8
16.35
38.9
Revenue Growth (3Y)(%) 8.90
STE's Revenue Growth (3Y)(%) is ranked higher than
69% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. STE: 8.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
STE' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0.6  Med: 7.10 Max: 10.6
Current: 8.9
0.6
10.6
EBITDA Growth (3Y)(%) 3.10
STE's EBITDA Growth (3Y)(%) is ranked lower than
58% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.30 vs. STE: 3.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
STE' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -18.3  Med: 6.70 Max: 69.2
Current: 3.1
-18.3
69.2
EPS Growth (3Y)(%) -0.90
STE's EPS Growth (3Y)(%) is ranked lower than
62% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. STE: -0.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
STE' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -72.2  Med: 7.50 Max: 305.1
Current: -0.9
-72.2
305.1
» STE's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-04)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

STE Guru Trades in Q2 2015

Joel Greenblatt 495,801 sh (New)
Jim Simons 214,700 sh (New)
Paul Tudor Jones 21,885 sh (+106.46%)
RS Investment Management 1,069,123 sh (+12.78%)
Mario Gabelli 111,000 sh (unchged)
Ken Fisher 1,613,251 sh (-0.70%)
Chuck Royce 801,841 sh (-11.16%)
Jeremy Grantham 7,900 sh (-57.98%)
» More
Q3 2015

STE Guru Trades in Q3 2015

Steven Cohen 215,800 sh (New)
Ray Dalio 6,505 sh (New)
RS Investment Management 1,429,523 sh (+33.71%)
Jim Simons 244,600 sh (+13.93%)
Ken Fisher 1,620,543 sh (+0.45%)
Jeremy Grantham 7,900 sh (unchged)
Mario Gabelli 110,000 sh (-0.90%)
Chuck Royce 610,441 sh (-23.87%)
Paul Tudor Jones 12,600 sh (-42.43%)
Joel Greenblatt 61,303 sh (-87.64%)
» More
Q4 2015

STE Guru Trades in Q4 2015

Paul Singer 366,180 sh (New)
John Keeley 3,125 sh (New)
Jeremy Grantham 78,892 sh (+898.63%)
Paul Tudor Jones 18,300 sh (+45.24%)
Chuck Royce 610,441 sh (unchged)
Ray Dalio Sold Out
Mario Gabelli Sold Out
Joel Greenblatt Sold Out
Ken Fisher 1,616,613 sh (-0.24%)
RS Investment Management 1,416,008 sh (-0.95%)
Steven Cohen 151,900 sh (-29.61%)
Jim Simons 146,100 sh (-40.27%)
» More
Q1 2016

STE Guru Trades in Q1 2016

Mario Gabelli 103,000 sh (New)
John Keeley 3,125 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Paul Singer Sold Out
Ken Fisher 1,613,920 sh (-0.17%)
Chuck Royce 572,383 sh (-6.23%)
Jeremy Grantham 71,992 sh (-8.75%)
RS Investment Management 1,182,867 sh (-16.46%)
Paul Tudor Jones 7,300 sh (-60.11%)
» More
» Details

Insider Trades

Latest Guru Trades with STE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NYSE:WAT, NYSE:MTD, NAS:HOLX, NYSE:RMD, NYSE:COO, NAS:SIRO » details
Traded in other countries:1S4.Germany,
STERIS PLC is a provider of infection prevention and other procedural products and services, focused on healthcare, pharmaceutical and research.

STERIS PLC, formerly Steris Corp was founded as Innovative Medical Technologies in Ohio in 1985, and renamed STERIS Corporation in 1987. The Company is a provider of infection prevention and other procedural products and services, focused on healthcare, pharmaceutical and research. It offers a mix of capital equipment products, such as sterilizers and surgical tables, and connectivity solutions such as operating room ('OR') integration; consumable products, such as detergents and skin care products, gastrointestinal ('GI') endoscopy accessories, and other products; services, including equipment installation and maintenance; and microbial reduction of medical devices, instrument and scope repair solutions, and laboratory testing services. The Company operates in three business segments: Healthcare, Life Sciences, and Isomedix. Healthcare segment manufactures and sells capital equipment, accessory, consumable, and service solutions to healthcare providers, including acute care hospitals, surgery and gastrointestinal centers. Brand names for these products include SYSTEM 1E, Amsco, Hamo, Reliance, Cmax, Harmony, Kindest Kare, Alcare, Verify, Cal Stat, Roth Net, Little Sister, and T-Series. Life Sciences segment manufactures and sells capital equipment, formulated cleaning chemistries, and service solutions to pharmaceutical companies, and private and public research facilities. Brand names for these products include Amsco, Reliance, Finn-Aqua, VHP, and the CIP Products.Isomedix segment sells comprehensive array of contract sterilization services using gamma irradiation and ethylene oxide ("EO") technologies as well as an array of laboratory testing services. Its competitors include 3M, Belimed, Cantel Medical, Ecolab, Getinge, Go Jo, Johnson & Johnson, Kimberly-Clark, Skytron, and Stryker. The Company is subject to various laws and governmental regulations concerning environmental matters and employee safety and health in the United States and in other countries.

Ratios

vs
industry
vs
history
P/E(ttm) 47.20
STE's P/E(ttm) is ranked lower than
77% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.90 vs. STE: 47.20 )
Ranked among companies with meaningful P/E(ttm) only.
STE' s P/E(ttm) Range Over the Past 10 Years
Min: 11.06  Med: 21.78 Max: 54.91
Current: 47.2
11.06
54.91
Forward P/E 25.91
STE's Forward P/E is ranked lower than
74% of the 39 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.28 vs. STE: 25.91 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 47.20
STE's PE(NRI) is ranked lower than
77% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.90 vs. STE: 47.20 )
Ranked among companies with meaningful PE(NRI) only.
STE' s PE(NRI) Range Over the Past 10 Years
Min: 11.08  Med: 22.08 Max: 54.83
Current: 47.2
11.08
54.83
Price/Owner Earnings (ttm) 47.39
STE's Price/Owner Earnings (ttm) is ranked lower than
75% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.16 vs. STE: 47.39 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
STE' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 8.36  Med: 18.12 Max: 49.42
Current: 47.39
8.36
49.42
P/B 1.96
STE's P/B is ranked higher than
64% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.69 vs. STE: 1.96 )
Ranked among companies with meaningful P/B only.
STE' s P/B Range Over the Past 10 Years
Min: 1.68  Med: 2.40 Max: 4.19
Current: 1.96
1.68
4.19
P/S 2.19
STE's P/S is ranked higher than
55% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. STE: 2.19 )
Ranked among companies with meaningful P/S only.
STE' s P/S Range Over the Past 10 Years
Min: 0.95  Med: 1.55 Max: 2.41
Current: 2.19
0.95
2.41
PFCF 53.00
STE's PFCF is ranked lower than
88% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. STE: 53.00 )
Ranked among companies with meaningful PFCF only.
STE' s PFCF Range Over the Past 10 Years
Min: 8.77  Med: 22.83 Max: 113.68
Current: 53
8.77
113.68
POCF 23.22
STE's POCF is ranked lower than
74% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.11 vs. STE: 23.22 )
Ranked among companies with meaningful POCF only.
STE' s POCF Range Over the Past 10 Years
Min: 7.12  Med: 13.27 Max: 25.64
Current: 23.22
7.12
25.64
EV-to-EBIT 40.22
STE's EV-to-EBIT is ranked lower than
77% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.76 vs. STE: 40.22 )
Ranked among companies with meaningful EV-to-EBIT only.
STE' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.2  Med: 13.70 Max: 40.2
Current: 40.22
7.2
40.2
EV-to-EBITDA 24.89
STE's EV-to-EBITDA is ranked lower than
74% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.58 vs. STE: 24.89 )
Ranked among companies with meaningful EV-to-EBITDA only.
STE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.4  Med: 9.65 Max: 24.9
Current: 24.89
5.4
24.9
PEG 4.91
STE's PEG is ranked lower than
80% of the 60 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.50 vs. STE: 4.91 )
Ranked among companies with meaningful PEG only.
STE' s PEG Range Over the Past 10 Years
Min: 0.59  Med: 2.45 Max: 15.61
Current: 4.91
0.59
15.61
Shiller P/E 37.13
STE's Shiller P/E is ranked lower than
52% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 36.18 vs. STE: 37.13 )
Ranked among companies with meaningful Shiller P/E only.
STE' s Shiller P/E Range Over the Past 10 Years
Min: 17.91  Med: 26.23 Max: 40.97
Current: 37.13
17.91
40.97
Current Ratio 2.68
STE's Current Ratio is ranked higher than
53% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. STE: 2.68 )
Ranked among companies with meaningful Current Ratio only.
STE' s Current Ratio Range Over the Past 10 Years
Min: 1.49  Med: 2.34 Max: 3.57
Current: 2.68
1.49
3.57
Quick Ratio 2.10
STE's Quick Ratio is ranked higher than
60% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. STE: 2.10 )
Ranked among companies with meaningful Quick Ratio only.
STE' s Quick Ratio Range Over the Past 10 Years
Min: 1.18  Med: 1.67 Max: 2.84
Current: 2.1
1.18
2.84
Days Inventory 50.52
STE's Days Inventory is ranked higher than
89% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.38 vs. STE: 50.52 )
Ranked among companies with meaningful Days Inventory only.
STE' s Days Inventory Range Over the Past 10 Years
Min: 53.59  Med: 64.10 Max: 70.76
Current: 50.52
53.59
70.76
Days Sales Outstanding 76.88
STE's Days Sales Outstanding is ranked lower than
70% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.03 vs. STE: 76.88 )
Ranked among companies with meaningful Days Sales Outstanding only.
STE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.38  Med: 71.33 Max: 82.3
Current: 76.88
62.38
82.3
Days Payable 37.92
STE's Days Payable is ranked lower than
67% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.30 vs. STE: 37.92 )
Ranked among companies with meaningful Days Payable only.
STE' s Days Payable Range Over the Past 10 Years
Min: 32.43  Med: 36.71 Max: 47
Current: 37.92
32.43
47

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.41
STE's Dividend Yield is ranked higher than
51% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.41 vs. STE: 1.41 )
Ranked among companies with meaningful Dividend Yield only.
STE' s Dividend Yield Range Over the Past 10 Years
Min: 0.15  Med: 1.36 Max: 2.34
Current: 1.41
0.15
2.34
Dividend Payout 0.66
STE's Dividend Payout is ranked lower than
66% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.38 vs. STE: 0.66 )
Ranked among companies with meaningful Dividend Payout only.
STE' s Dividend Payout Range Over the Past 10 Years
Min: 0.11  Med: 0.25 Max: 1.79
Current: 0.66
0.11
1.79
Dividend Growth (3y) 10.90
STE's Dividend Growth (3y) is ranked lower than
56% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.90 vs. STE: 10.90 )
Ranked among companies with meaningful Dividend Growth (3y) only.
STE' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 34.7
Current: 10.9
0
34.7
Forward Dividend Yield 1.44
STE's Forward Dividend Yield is ranked higher than
50% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. STE: 1.44 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 2.81
STE's Yield on cost (5-Year) is ranked higher than
64% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.91 vs. STE: 2.81 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
STE' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.3  Med: 2.71 Max: 4.67
Current: 2.81
0.3
4.67
3-Year Average Share Buyback Ratio -1.10
STE's 3-Year Average Share Buyback Ratio is ranked higher than
66% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.90 vs. STE: -1.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
STE' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.1  Med: 0.15 Max: 5.2
Current: -1.1
-1.1
5.2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.52
STE's Price/Projected FCF is ranked higher than
62% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.89 vs. STE: 1.52 )
Ranked among companies with meaningful Price/Projected FCF only.
STE' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.83  Med: 1.44 Max: 14.78
Current: 1.52
0.83
14.78
Price/DCF (Earnings Based) 3.44
STE's Price/DCF (Earnings Based) is ranked lower than
79% of the 19 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. STE: 3.44 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.41
STE's Price/Median PS Value is ranked lower than
69% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.06 vs. STE: 1.41 )
Ranked among companies with meaningful Price/Median PS Value only.
STE' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.54  Med: 1.03 Max: 1.95
Current: 1.41
0.54
1.95
Price/Peter Lynch Fair Value 4.79
STE's Price/Peter Lynch Fair Value is ranked lower than
85% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.44 vs. STE: 4.79 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
STE' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.45  Med: 1.92 Max: 41.83
Current: 4.79
0.45
41.83
Earnings Yield (Greenblatt) (%) 2.50
STE's Earnings Yield (Greenblatt) (%) is ranked higher than
54% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. STE: 2.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STE' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.5  Med: 7.30 Max: 13.8
Current: 2.5
2.5
13.8
Forward Rate of Return (Yacktman) (%) 12.25
STE's Forward Rate of Return (Yacktman) (%) is ranked higher than
62% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.41 vs. STE: 12.25 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
STE' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 7.1  Med: 13.10 Max: 37.8
Current: 12.25
7.1
37.8

More Statistics

Revenue (TTM) (Mil) $2,239
EPS (TTM) $ 1.47
Beta1.36
Short Percentage of Float8.30%
52-Week Range $60.75 - 78.77
Shares Outstanding (Mil)85.90

Analyst Estimate

Mar17 Mar18
Revenue (Mil $) 2,793 2,961
EPS ($) 2.68 3.88
EPS without NRI ($) 2.68 3.88
EPS Growth Rate
(3Y to 5Y Estimate)
14.00%
» More Articles for NYSE:STE

Headlines

Articles On GuruFocus.com
16 Best Dividend Paying Healthcare Stocks Sep 03 2012 
Supply Your Portfolio with Healthy Growth from Medical Suppliers May 25 2012 
STERIS Corp. Reports Operating Results (10-Q) Feb 09 2011 
STERIS Corp. Reports Operating Results (10-Q) Nov 09 2010 
STERIS Corp. (STE) President & CEO Walter M Jr Rosebrough sells 11,600 Shares Oct 01 2010 
STERIS Corp. (STE) SVP & CFO Michael J Tokich sells 9,000 Shares Apr 09 2010 
STERIS Corp. Reports Operating Results (10-Q) Feb 09 2010 
Robert Olstein on Hedge Fund regulations. Recent Olstein buys. Jan 15 2010 
STERIS Corp. Reports Operating Results (10-Q) Nov 03 2009 
STERIS Corp. (STE) President & CEO Walter M Jr Rosebrough sells 5,000 Shares Oct 02 2009 

More From Other Websites
STERIS plc to Participate in the Jefferies Global Healthcare Conference May 25 2016
STERIS plc to Participate in the Jefferies Global Healthcare Conference May 25 2016
STERIS (STE): Q4 Results Strong, Currency Woes Remain May 23 2016
STERIS Plc :STE-US: Earnings Analysis: Q4, 2016 By the Numbers May 20 2016
ETF’s with exposure to STERIS Plc : May 19, 2016 May 19 2016
STERIS (STE) Misses on Q4 Earnings, Higher Tax a Concern May 19 2016
Steris (STE) Stock Slumps as Q4 Results Miss Estimates May 18 2016
Edited Transcript of STE earnings conference call or presentation 18-May-16 2:00pm GMT May 18 2016
STERIS Plc breached its 50 day moving average in a Bearish Manner : STE-US : May 18, 2016 May 18 2016
STERIS plc Announces Financial Results for Fiscal 2016 Fourth Quarter and Full Year; Provides Fiscal... May 18 2016
Q4 2016 Steris PLC Earnings Release - Before Market Open May 18 2016
Steris misses Street 4Q forecasts May 18 2016
Steris misses Street 4Q forecasts May 18 2016
STERIS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or... May 18 2016
STERIS plc Announces Financial Results for Fiscal 2016 Fourth Quarter and Full Year; Provides Fiscal... May 18 2016
5 Stocks Set to Soar on Bullish Earnings May 16 2016
Rescission of the lock-up agreement between Servizi Italia, Steris Corp. ad Steris UK May 04 2016
STERIS plc to Announce Fiscal 2016 Fourth Quarter and Full Year Financial Results on May 18, 2016 May 03 2016
STERIS plc to Announce Fiscal 2016 Fourth Quarter and Full Year Financial Results on May 18, 2016 May 03 2016
Strenghtening of the partnership with Steris. Execution of the share capital increase. Apr 06 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)